AD
Antal Rohit Desai
Director

Antal Rohit Desai insider trades: PROCEPT BioRobotics (PRCT) stock buys and sales

Director, PROCEPT BioRobotics Last trade Mar 9, 2026 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$10.5M
Bought, last 12 months
1 buy
8
Open-market trades
since 2021
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Antal reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 9, 2026PRCT↑ Buy$10.5M
Jun 12, 2025PRCT↓ Sell$4.7M
Jun 5, 2025PRCT↓ Sell$4.7M
Nov 7, 2024PRCT↓ Sell$9.6M
Sep 12, 2024PRCT↓ Sell$9.4M
Sep 5, 2024PRCT↓ Sell$3.7M
Sep 4, 2024PRCT↓ Sell$4.0M
Sep 17, 2021PRCT↑ Buy$11.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PRCT insiders

Open-market trades in the last 12 months

About Antal Rohit Desai's insider trades

Antal Rohit Desai is a director at PROCEPT BioRobotics (PRCT). Since Sep 17, 2021, Antal has reported 2 open-market purchases worth $21.5M and 6 sales worth $36.1M on SEC Form 4. In the last 12 months: 1 buy ($10.5M).

Their filings also include other transactions (8 filings), grants and awards (6 filings), shares returned to the company (2 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.